Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from children and adolescents treated with Fluoxetine

ABSTRACT: Expression data from children and adolescents treated with Fluoxetine

PROVIDER: PRJNA527307 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Expression data from children and adolescents treated with Fluoxetine

Project description:It is well-known that between 40 and 50% of patients taking antidepressants do not respond to treatment or relapse. Genome wide gene expression studies can help us to understand better the response to antidepressants, revealing the effects of both genetic background and environmental/epigenetic factors. We used microarrays to detail the response to Fluoxetine in children and adolescents, analysing the expression just before intake of drug and 8 weeks after starting the treatment.

2019-12-31 | GSE128387 | GEO

GastroIntestinal Cancer in Children and Adolescents

Project description:The goal of this observational population-based cohort study is to investigate the clinical characteristics and outcomes of children and adolescents with primary gastrointestinal malignancies registered in the publicly available Surveillance, Epidemiology, and End Results (SEER) 17 database during 2000-2019.

| 5683 | ecrin-mdr-crc

Epigenomic analysis of eating disorders in children and adolescents of Mexican ancestry

Project description:This study included whole-genome DNA methylation data from 64 whole-blood samples from patients recruited from the Hospital Psiquiatrico Infantil Juan N. Navarro in Mexico City. The project explored epigenetic changes associated with eating disorders in children and adolescents from a Mexican population.

2022-04-27 | GSE201638 | GEO

Tear Proteomics Analysis in Children and Adolescents with Type 1 Diabetes

Project description:Fifty-six children and adolescents with type 1 diabetes at least one year after diagnosis, aged 6-17 years old and fifty-six healthy age- and sex-matched subjects were enrolled in this cross-sectional study. Tear samples were collected using Schirmer strips placed on the lower eyelid. The proteomic analysis was based on a detergent-assisted protein extraction and their digestion from the tears, analysis of the tryptic peptides with LC-MS/ enabling the identification, and quantification of the Shirmer strip protein content via DIA-NN, and subsequently the statistical and bioinformatic analysis using the R and Metascape enrichment analysis tool.

2024-10-17 | PXD052994 | Pride

Gene expression profile of S-180 tumour cells after treated with Fluoxetine 20uM for 12hr.

Project description:To understand changes in gene expression profile of S-180 cells in response to Fluoxetine treated for 12hr.

2025-05-14 | GSE270843 | GEO

Gene expression microarray analysis on the dentate gyrus of mice chronically treated with fluoxetine

Project description:The gene expression patterns in the dentate gyrus of wild-type mice treated with fluoxetine (15 mg/kg/day for 3 weeks) or vehicle were examined using Affymetrix GeneChip arrays.

2019-02-25 | GSE118669 | GEO

Gene expression microarray analysis on the medial prefrontal cortex of mice chronically treated with fluoxetine

Project description:The gene expression patterns in the medial prefrontal cortex of wild-type mice treated with fluoxetine (15 mg/kg/day for 3 weeks) or vehicle were examined using Affymetrix GeneChip arrays.

2019-02-25 | GSE118668 | GEO

Comprehensive Analysis of Relapsed-Refractory Mature B-cell Non-Hodgkin Lymphoma in Children and Adolescents

Project description:Outcome of paediatric B-cell Non-Hodgkin Lymphoma (B-NHL) has significantly improved in the last decades due to risk adapted strategies and the addition of immunotherapy, (survival >90%). However, limited progress has been achieved in relapsed patients, mostly Burkitt lymphoma (<30%). Validation of prognostic biomarkers to identify candidates to novel therapies is imperative. This retrospective study reports on clinical and therapeutic data of 46 children and adolescents with relapsed B-NHL, including integrative molecular data of 16 (35%) cases. TP53 alterations were identified in 10 (60%) patients which were associated with worse outcome. Our data support the focus on TP53 as a potential biomarker.

2025-02-27 | GSE269220 | GEO

Periconceptional folic acid supplementation and DNA methylation patterns in adolescents

Project description:DNA methylation profiles from saliva collected from 89 mothers and 179 adolescent children who received or did not receive perinatal folic acid supplementation Periconceptional folic acid supplementation and DNA methylation patterns in adolescents

2023-01-18 | GSE212564 | GEO

Epigenomic analysis of eating disorders in children and adolescents of Mexican ancestry

Project description:Epigenomic analysis of eating disorders in children and adolescents of Mexican ancestry

| PRJNA832413 | ENA